Skip to main navigation
Skip to search
Skip to main content
Projects and Grants
Press / Media
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Compare the safety and efficacy of 200 mg PAR-101 Taken
Young, Jo-Anne H
Medicine - Infectious Disease and International
Compare the safety and efficacy of 200 mg PAR-101 Taken q12h with 125 mg Vancomycin taken q6h for ten days in Subjects with clostridium difficile-associated diarrhea
Effective start/end date
Optimer Pharmaceuticals, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Engineering & Materials Science